These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 20890981)

  • 21. Metabolic syndrome in Tunisian psoriatic patients: prevalence and determinants.
    Mebazaa A; El Asmi M; Zidi W; Zayani Y; Cheikh Rouhou R; El Ounifi S; Kanoun F; Mokni M; Osman AB; Feki M; Slimane H; Mebazaa A; Kaabachi N
    J Eur Acad Dermatol Venereol; 2011 Jun; 25(6):705-9. PubMed ID: 21029207
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence of metabolic syndrome in patients with psoriasis.
    Nisa N; Qazi MA
    Indian J Dermatol Venereol Leprol; 2010; 76(6):662-5. PubMed ID: 21079309
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association between the metabolic syndrome and its components and gait speed among U.S. adults aged 50 years and older: a cross-sectional analysis.
    Okoro CA; Zhong Y; Ford ES; Balluz LS; Strine TW; Mokdad AH
    BMC Public Health; 2006 Nov; 6():282. PubMed ID: 17105659
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metabolic syndrome in Saudi Arabia.
    Al-Nozha M; Al-Khadra A; Arafah MR; Al-Maatouq MA; Khalil MZ; Khan NB; Al-Mazrou YY; Al-Marzouki K; Al-Harthi SS; Abdullah M; Al-Shahid MS; Al-Mobeireek A; Nouh MS
    Saudi Med J; 2005 Dec; 26(12):1918-25. PubMed ID: 16380773
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Using structural equation model to illustrate the relationship between metabolic risk factors and cardiovascular complications in Taiwan.
    Lin JW; Hwang JJ; Dai DF; Tseng YZ
    Eur J Cardiovasc Prev Rehabil; 2006 Aug; 13(4):633-9. PubMed ID: 16874156
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence of metabolic syndrome among Filipino adults aged 20 years and over.
    Tanchoco CC; Cruz AJ; Duante CA; Litonjua AD
    Asia Pac J Clin Nutr; 2003; 12(3):271-6. PubMed ID: 14505989
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Associations of obesity with modifiable risk factors for the development of cardiovascular disease in patients with rheumatoid arthritis.
    Stavropoulos-Kalinoglou A; Metsios GS; Panoulas VF; Douglas KM; Nevill AM; Jamurtas AZ; Kita M; Koutedakis Y; Kitas GD
    Ann Rheum Dis; 2009 Feb; 68(2):242-5. PubMed ID: 18677010
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differences in body mass index among individuals with PsA, psoriasis, RA and the general population.
    Bhole VM; Choi HK; Burns LC; Vera Kellet C; Lacaille DV; Gladman DD; Dutz JP
    Rheumatology (Oxford); 2012 Mar; 51(3):552-6. PubMed ID: 22120603
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prediction of cardiovascular events in patients with ankylosing spondylitis and psoriatic arthritis: role of lipoproteins in a high-risk population.
    Semb AG; Kvien TK; DeMicco DA; Fayyad R; Wun CC; LaRosa J; Betteridge J; Pedersen TR; Holme I
    J Rheumatol; 2012 Jul; 39(7):1433-40. PubMed ID: 22660802
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence of the metabolic syndrome is increased in rheumatoid arthritis and is associated with coronary atherosclerosis.
    Chung CP; Oeser A; Solus JF; Avalos I; Gebretsadik T; Shintani A; Raggi P; Sokka T; Pincus T; Stein CM
    Atherosclerosis; 2008 Feb; 196(2):756-63. PubMed ID: 17266963
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Healthcare and burden of disease in psoriatic arthritis. A comparison with rheumatoid arthritis and ankylosing spondylitis.
    Zink A; Thiele K; Huscher D; Listing J; Sieper J; Krause A; Gromnica-Ihle E; von Hinueber U; Wassenberg S; Genth E; Schneider M;
    J Rheumatol; 2006 Jan; 33(1):86-90. PubMed ID: 16395755
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardiovascular risk in rheumatoid arthritis versus osteoarthritis: acute phase response related decreased insulin sensitivity and high-density lipoprotein cholesterol as well as clustering of metabolic syndrome features in rheumatoid arthritis.
    Dessein PH; Stanwix AE; Joffe BI
    Arthritis Res; 2002; 4(5):R5. PubMed ID: 12223108
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of criteria for metabolic syndrome in a population-based study of Japanese-Brazilians.
    Rosenbaum P; Gimeno SG; Sanudo A; Franco LJ; Ferreira SR;
    Diabetes Obes Metab; 2005 Jul; 7(4):352-9. PubMed ID: 15955121
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence of metabolic syndrome in patients with psoriasis: a hospital-based case-control study.
    Gisondi P; Tessari G; Conti A; Piaserico S; Schianchi S; Peserico A; Giannetti A; Girolomoni G
    Br J Dermatol; 2007 Jul; 157(1):68-73. PubMed ID: 17553036
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The metabolic syndrome among postmenopausal women in Ecuador.
    Hidalgo LA; Chedraui PA; Morocho N; Alvarado M; Chavez D; Huc A
    Gynecol Endocrinol; 2006 Aug; 22(8):447-54. PubMed ID: 17012107
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antibodies to tissue transglutaminase and Saccharomyces cerevisiae in ankylosing spondylitis and psoriatic arthritis.
    Riente L; Chimenti D; Pratesi F; Delle Sedie A; Tommasi S; Tommasi C; Bombardieri S; Migliorini P
    J Rheumatol; 2004 May; 31(5):920-4. PubMed ID: 15124251
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical profile and outcome of patients with chronic inflammatory arthritis and metabolic syndrome.
    Cioffi G; Viapiana O; Tarantini L; Orsolini G; Idolazzi L; Sonographer FO; Dalbeni A; Gatti D; Fassio A; Rossini M; Giollo A
    Intern Emerg Med; 2021 Jun; 16(4):863-874. PubMed ID: 33083946
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The prevalence of metabolic syndrome among young adults in Izmir, Turkey.
    Soysal A; Demiral Y; Soysal D; Uçku R; Köseoğlu M; Aksakoğlu G
    Anadolu Kardiyol Derg; 2005 Sep; 5(3):196-201. PubMed ID: 16140651
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence of metabolic syndrome in the Mediterranean region of Turkey: evaluation of hypertension, diabetes mellitus, obesity, and dyslipidemia.
    Gündogan K; Bayram F; Capak M; Tanriverdi F; Karaman A; Ozturk A; Altunbas H; Gökce C; Kalkan A; Yazici C
    Metab Syndr Relat Disord; 2009 Oct; 7(5):427-34. PubMed ID: 19754305
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Obesity and abdominal obesity; an alarming challenge for cardio-metabolic risk in Turkish adults.
    Oğuz A; Temizhan A; Abaci A; Kozan O; Erol C; Ongen Z; Celik S
    Anadolu Kardiyol Derg; 2008 Dec; 8(6):401-6. PubMed ID: 19103534
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.